Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | decreases expression | ISO | Tagln3 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of TAGLN3 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | increases expression | ISO | Tagln3 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of TAGLN3 mRNA | CTD | PMID:22206623 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:31675489 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Tagln3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of TAGLN3 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TAGLN3 mRNA | CTD | PMID:32109520 | 2,4,6-tribromophenol | decreases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:31675489 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | tetrabromobisphenol A results in decreased expression of TAGLN3 protein | CTD | PMID:31675489 | 3H-1,2-dithiole-3-thione | increases expression | EXP | | 6480464 | 1 and 2-dithiol-3-thione results in increased expression of TAGLN3 mRNA | CTD | PMID:19162173 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | TAGLN3 (Homo sapiens) | 6480464 | [bisphenol S co-treated with Fulvestrant] results in decreased methylation of TAGLN3 gene | CTD | PMID:31601247 | 5-aza-2'-deoxycytidine | affects expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | Decitabine affects the expression of TAGLN3 mRNA | CTD | PMID:23300844 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of TAGLN3 mRNA | CTD | PMID:24780913 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of TAGLN3 mRNA | CTD | PMID:20488242 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of TAGLN3 mRNA | CTD | PMID:16483693 | aristolochic acid A | increases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of TAGLN3 mRNA and aristolochic acid I results in increased expression of TAGLN3 protein | CTD | PMID:33212167 | arsenite(3-) | increases methylation | ISO | TAGLN3 (Homo sapiens) | 6480464 | arsenite results in increased methylation of TAGLN3 promoter | CTD | PMID:23974009 | benzo[a]pyrene | decreases expression | ISO | Tagln3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of TAGLN3 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | decreases methylation | ISO | TAGLN3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of TAGLN3 exon and Benzo(a)pyrene results in decreased methylation of TAGLN3 promoter | CTD | PMID:27901495 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of TAGLN3 mRNA | CTD | PMID:31163220 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of TAGLN3 mRNA | CTD | PMID:18180321 | bisphenol A | decreases expression | ISO | Tagln3 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of TAGLN3 mRNA | CTD | PMID:32156529 and PMID:35598803 | bisphenol A | decreases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of TAGLN3 protein | CTD | PMID:31675489 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of TAGLN3 gene | CTD | PMID:28505145 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of TAGLN3 mRNA | CTD | PMID:25181051 more ... | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of TAGLN3 mRNA | CTD | PMID:33453195 | chlordecone | increases expression | ISO | Tagln3 (Mus musculus) | 6480464 | Chlordecone results in increased expression of TAGLN3 mRNA | CTD | PMID:33711761 | chlorpyrifos | decreases expression | ISO | Tagln3 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of TAGLN3 mRNA | CTD | PMID:37019170 | ciguatoxin CTX1B | affects expression | ISO | Tagln3 (Mus musculus) | 6480464 | Ciguatoxins affects the expression of TAGLN3 mRNA | CTD | PMID:18353800 | cisplatin | affects expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | Cisplatin affects the expression of TAGLN3 mRNA | CTD | PMID:23300844 | cocaine | decreases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | Cocaine results in decreased expression of TAGLN3 mRNA | CTD | PMID:12629581 | copper atom | multiple interactions | ISO | Tagln3 (Mus musculus) | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TAGLN3 mRNA | CTD | PMID:15467011 | copper(0) | multiple interactions | ISO | Tagln3 (Mus musculus) | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TAGLN3 mRNA | CTD | PMID:15467011 | cyclosporin A | increases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of TAGLN3 mRNA | CTD | PMID:25562108 | daunorubicin | affects response to substance | ISO | TAGLN3 (Homo sapiens) | 6480464 | TAGLN3 affects the susceptibility to Daunorubicin | CTD | PMID:17545624 | DDT | decreases methylation | EXP | | 6480464 | DDT results in decreased methylation of TAGLN3 gene | CTD | PMID:31682807 | decabromodiphenyl ether | decreases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | decabromobiphenyl ether results in decreased expression of TAGLN3 protein | CTD | PMID:31675489 | dorsomorphin | multiple interactions | ISO | TAGLN3 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | entinostat | decreases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | entinostat results in decreased expression of TAGLN3 mRNA | CTD | PMID:26272509 and PMID:27188386 | entinostat | multiple interactions | ISO | TAGLN3 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TAGLN3 mRNA | CTD | PMID:27188386 | ethanol | increases expression | ISO | Tagln3 (Mus musculus) | 6480464 | Ethanol results in increased expression of TAGLN3 mRNA | CTD | PMID:30319688 | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of TAGLN3 mRNA | CTD | PMID:30307764 | fulvestrant | multiple interactions | ISO | TAGLN3 (Homo sapiens) | 6480464 | [bisphenol S co-treated with Fulvestrant] results in decreased methylation of TAGLN3 gene | CTD | PMID:31601247 | isotretinoin | decreases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | Isotretinoin results in decreased expression of TAGLN3 mRNA | CTD | PMID:20436886 | ivermectin | decreases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of TAGLN3 protein | CTD | PMID:32959892 | ketamine | increases expression | EXP | | 6480464 | Ketamine results in increased expression of TAGLN3 protein | CTD | PMID:18504422 | lead(0) | affects expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | Lead affects the expression of TAGLN3 mRNA | CTD | PMID:28903495 | lead(0) | affects splicing | ISO | TAGLN3 (Homo sapiens) | 6480464 | Lead affects the splicing of TAGLN3 mRNA | CTD | PMID:28903495 | lipopolysaccharide | multiple interactions | ISO | TAGLN3 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of TAGLN3 mRNA | CTD | PMID:35811015 | methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of TAGLN3 protein | CTD | PMID:19826936 | ochratoxin A | increases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | ochratoxin A results in increased expression of TAGLN3 mRNA | CTD | PMID:30559759 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of TAGLN3 mRNA | CTD | PMID:33387578 | phenethyl isothiocyanate | increases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | phenethyl isothiocyanate results in increased expression of TAGLN3 mRNA | CTD | PMID:26678675 | S-(1,2-dichlorovinyl)-L-cysteine | increases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | S-(1 and 2-dichlorovinyl)cysteine results in increased expression of TAGLN3 mRNA | CTD | PMID:35811015 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | TAGLN3 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of TAGLN3 mRNA | CTD | PMID:35811015 | sarin | increases expression | EXP | | 6480464 | Sarin results in increased expression of TAGLN3 protein | CTD | PMID:28973502 | SB 431542 | multiple interactions | ISO | TAGLN3 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:37664457 | silicon dioxide | increases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of TAGLN3 mRNA | CTD | PMID:25895662 | temozolomide | decreases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of TAGLN3 mRNA | CTD | PMID:31758290 | thapsigargin | decreases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | Thapsigargin results in decreased expression of TAGLN3 mRNA | CTD | PMID:22378314 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of TAGLN3 mRNA | CTD | PMID:33387578 | trichostatin A | decreases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of TAGLN3 mRNA | CTD | PMID:24935251 | triptonide | increases expression | ISO | Tagln3 (Mus musculus) | 6480464 | triptonide results in increased expression of TAGLN3 mRNA | CTD | PMID:33045310 | tunicamycin | decreases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | Tunicamycin results in decreased expression of TAGLN3 mRNA | CTD | PMID:22378314 | urethane | decreases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | Urethane results in decreased expression of TAGLN3 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of TAGLN3 mRNA | CTD | PMID:29154799 | valproic acid | affects expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of TAGLN3 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | TAGLN3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of TAGLN3 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | TAGLN3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TAGLN3 mRNA | CTD | PMID:27188386 | WIN 55212-2 | decreases expression | ISO | Tagln3 (Mus musculus) | 6480464 | (3R)-((2 more ... | CTD | PMID:12237329 | |